false
Catalog
Long-Term Antidepressant Treatment: Let's Look at ...
Presentation Slides
Presentation Slides
Back to course
Pdf Summary
This document is from an APA (American Psychiatric Association) and SAMHSA (Substance Abuse and Mental Health Services Administration) initiative. It provides information about the long-term treatment of depression and the evidence supporting different treatment approaches. The document includes a funding statement and information about continuing education credits for physicians.<br /><br />The document lists learning objectives that include assessing the risk of depressive relapse and recurrence, summarizing the strengths and weaknesses of long-term antidepressant treatment, and describing the strengths and weaknesses of psychotherapy alone in preventing recurrent depressive episodes.<br /><br />It also includes references to studies and research findings about different treatment options, including various antidepressants, psychosocial interventions, Vilazodone, Levomilnacipran, Vortioxetine, IV Ketamine, rTMS, antipsychotic continuation for psychotic depression, brexanolone for postpartum depression, ECT, antidepressants with or without cognitive therapy, well-being therapy, online mindfulness-based CBT, and guidelines for maintenance treatment.<br /><br />The document concludes with information about accessing the SMI Adviser mobile app, requesting a consultation, and other SAMHSA initiatives. It also provides instructions on how to claim credit for the webinar and announces an upcoming webinar about trauma-informed peer support and post-traumatic growth.
Keywords
long-term treatment
depression
evidence
antidepressant treatment
psychotherapy
recurrent depressive episodes
antidepressants
psychosocial interventions
maintenance treatment
webinar
Funding for SMI Adviser was made possible by Grant No. SM080818 from SAMHSA of the U.S. Department of Health and Human Services (HHS). The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement by, SAMHSA/HHS or the U.S. Government.
×
Please select your language
1
English